Whole Genome Sequencing for the identification of mutations in any disease-linked genes or gene(s) of patient interest. User-friendly website and mobile portal for results, questions, and consultations. FDA-approved 15 second nasal swabs, CLIA and CAP compliant, hassle-free prepaid shipping.
Targeted Disease Sequencing (includes diseases such as pancreatic diseases (diabetes, cancer), Alzheimer's disease, Cardiovascular disease (heart), Amyotrophic Lateral Sclerosis) - any disease any genes. PDx covers >1000 times more coverage than 23 and Me, and Ancestry, to ensure no false-hope.
Annual subscriptions are available for the detection of spontaneous, "de novo" mutations.
Get your fully sequenced genome along with personalized analysis of your DNA (greater than 5000 times more coverage than 23 and Me, and Ancestry) to determine susceptibility to any diseases or genetic mutations including neurodegenerative disorders, cancers, cardiovascular, prenatal and more
To learn even more about your genetics you can always explore more diseases with your Whole Genome Sequencing Full-Service for a lifetime
Each gene is sequenced in its entirety; every nucleic acid in every part of the gene, that's the PDx approach to avoid false-hope.
APOE4, APP, PSEN1, PLD3, TREM2, UNC5, CPSEN2, APOE2, APOE3, ABCA7, CLU, CR1, PICALM, SORL1
SOD1, C9ORF72, NEK1, TDP43, FUS, UBQLN2, KIF5A, MATR3, TBK1, C21ORF2, TUBA4A
α synuclein (PARK1), Parkin (PARK2), UCHL-1 (PARK5), DJ-1 (PARK7), PINK1 (PARK6), LRRK2 (PARK8), NR4A2 (NURR1), PARK3, PARK4, PARK9, PARK10
Huntington (HTT), FAN1, MTMR10, RRM2B, URB5, MSH3
PluriPotent Diagnostics (PDx)
Copyright © 2021 PluriPotent Diagnostics - All Rights Reserved